Irritable bowel syndrome (IBS) is a complication that can follow gastrointestinal infection, but it is not clear if patients also develop chronic fatigue. We investigated the prevalence and odds ratio of IBS and chronic fatigue 10 years after an outbreak of Giardia lamblia, compared with a control cohort, and changes in prevalence over time.
I rritable bowel syndrome (IBS) is a functional gastrointestinal disorder that constitutes a substantial economic burden to society. 1 It is a common condition, with a pooled prevalence of 11.2%. 1 Chronic fatigue (CF) is another common complaint among patients seeking primary care, and 1 study found a prevalence of 24% in this population. 2 Despite its potentially debilitating features, it is less investigated. Fatigue is more commonly studied as part of the less prevalent CF syndrome (CFS). 3 IBS and CF or CFS share a lack of consistent biologic findings and both conditions are often categorized as functional disorders. 4 Etiology for both IBS and CF is incompletely understood, but both conditions have been associated with previous infections. 3, 5 Postinfectious IBS (PI-IBS) has been described following outbreaks, among travelers returning from abroad, or as sporadic cases. [5] [6] [7] [8] [9] [10] The rate of recovery from PI-IBS varies between studies, and bacterial infections seem to be associated with more prolonged symptoms than viral infections. 10 One study after an outbreak of bacterial dysentery reported that IBS was associated with exposure up to 8 years after the acute infection. 6 A more recent study found that IBS was associated with shigellosis after 1 and 3 years' postexposure follow-up, but not after 5, 8, or 10 years. 7 Postinfectious CF as part of CFS has been reported as a complication after various acute viral and bacterial infections. 3, [11] [12] [13] [14] In the autumn of 2004, the parasite Giardia lamblia contaminated 1 of the municipal drinking-water reservoirs in Bergen, likely due to broken sewage pipes. This is one of the largest waterborne outbreaks ever recorded in Norway, 15 and 1252 patients had laboratory confirmed giardiasis that was linked to the outbreak. 9 Several postinfectious conditions have been studied in this cohort over time, and our research group has previously found an association between Giardia lamblia infection and IBS and CF both 3 and 6 years after the acute illness. 8, 9 The prevalence fell from 3 to 6 years for both conditions.
The primary aim of the current study was to estimate the prevalence and odds ratio of IBS and CF 10 years after acute giardiasis relative to a control cohort. The secondary aims were to investigate changes in prevalence from 3 to 10 and from 6 to 10 years and to estimate incidence, recovery, and persistence of these conditions.
Methods

Participants
This study was a prospective follow-up of a cohort of 1252 patients (the exposed group) and a control group 3, 6, and 10 years after laboratory verified Giardia infection during a waterborne outbreak in the autumn of 2004. On our request, Statistics Norway established a 2:1 control group of 2504 individuals from Bergen matched by age and sex. There was a predominance of women in the exposed target population (61%, 764 of 1252). Children under 18 years of age were excluded from the data collection at the 10-year follow-up, and hence these children were retrospectively also excluded from all analyses based on the data collections at the 3-and 6-year follow-ups (Table 1) . Analyses of prevalence changes from 3 to 6 years 8 have been published previously, but were calculated anew for this study. 
Variables
The primary outcome variables were IBS and CF 10 years after giardiasis in the exposed and the control group, as well as the following subgroup categories: severe IBS, severe CF, IBS, and CF combined, IBS only and CF only. Secondary outcomes were changes in prevalence of IBS and CF from 3 to 10 years (for IBS and CF only), and from 6 to 10 years (all subgroup categories). Respondents who had either IBS or CF at all 3 follow-ups were defined as having a persistent condition.
IBS was defined according to the Rome III criteria, 16 where respondents who had recurrent abdominal pain or discomfort at least 3 days/month in the last 3 months were defined as having IBS if their pain or discomfort was also associated with 2 or more of the additional IBS criteria. These symptoms must also have had an onset at Target population 2007  1218  100  2436  100  3654  100  Study population 2007  802  66  843  35  1645  45  Lost to follow-up   d   13  58  Target population 2010  1205  100  2378  100  3583  100  Study population 2010  731  61  852  36  1583  44  Lost to follow-up   d   29  48  Target population 2015  1176  100  2330  100  3506  100  Questionnaires returned 2015  592  50  709  30  1301  37  Giardia during outbreak  6  Incomplete response  2  6  Withdrawn questionnaire  1  Nonresponders  584  1622  2206  Study population 2015  590  50  696  30  1286  37  Responded at all follow-ups  427  36  365  16 least 6 months before the response. When IBS limited daily activities at least often, we defined this as severe IBS. We also defined the IBS subtypes according to the Rome III criteria. 16 Fatigue was defined using the validated Fatigue Questionnaire. 17 The questionnaire consists of 13 questions, with 11 questions addressing different aspects of fatigue. The severity of fatigue was reported on a 4 item Likert-type scale with responses ranging from 0 (less than normal) to 3 (much more than normal). The scores were added for a total fatigue score (range, 0-33). The scores were also dichotomized (0 and 1 into 0, 2, and 3 into 1) and CF was defined as a dichotomized score of 4 or more, provided the symptoms had lasted 6 months or more. Severe fatigue was defined as CF with a total fatigue score of 23 or more. Cases with more than 4 missing answers on the 11 fatigue related questions were excluded from the analyses on CF. In cases with 4 or less missing responses the missing values were replaced with the mean of all the responses to that particular question.
Demographic variables recorded and evaluated as potential confounders were sex, age, marital status, educational level, and main occupation. Sex and age were additionally considered as potential interacting variables for the associations between the exposure and the outcomes.
Nonresponders were compared with responders on age and sex, and only included in nonresponder analyses.
Analyses and Statistical Methods
Descriptive statistics were calculated as percentage or mean. Fisher's exact 2-sided mid-P test in 2 Â 2 tables was used for binary outcomes, 18 and Pearson's chi square exact 2-sided test for associations in 2 Â k tables was used for multilevel outcomes. Gosset's unpaired t test was used to compare means for continuous variables. 19 Selection bias analyses were performed and details regarding these are available as supplementary text.
Prevalence at 10 years was compared between the Giardia exposed and controls using odds ratio (OR) with 95% confidence interval (CI). Binary logistic regression and cross-tabulations were used when analyzing CF and IBS to assess risk factors. Interactions were tested by the Breslow-Day test for homogeneity of odds ratios after stratification.
The attributable fraction among the exposed (AFE) was calculated as a percentage by the formula AFE % ¼ (1 -1/RR) Â 100%.
Changes in prevalence between follow-ups were calculated using binary logistic regression with the method of generalized estimating equations. This method accounts for correlation between repeated measures and the matched design. Data from all the respondents from all time points were included. The results from these analyses were presented as age-and sex-adjusted OR (aOR).
Frequencies of incident, recovered and persistent IBS or CF were calculated in 2 Â k tables. Associations between exposure and persisting IBS or CF were evaluated by binary logistic regression with calculations of age and sex aOR.
All tests were 2 sided with a level of statistical significance set to .05. All analyses were done using IBM SPSS Statistics for Windows, Version 24.0 (IBM Corp, Armonk, NY). Sankey diagrams used for Figure 1 and Supplementary Table 3 with figure were plotted using R 20 with the package sankeyD3. 21 
Results
The response rate at the 10-year follow-up was 50% (592 of 1176) among the exposed, and 30% (708 of 2330) among control subjects (Table 1 ). Responders to the 10-year questionnaire were older (43.3 years) than nonresponders (41.0 years, P < .001). There were more women among responders (857 of 1300, 66%) than among nonresponders (1307 of 2206, 59%; P < .001). Demographically, the exposed and the control group differed only in marital status after 10 years (Table 2) .
Results from selection bias analyses are available as supplementary text and Supplementary Tables 1 and 2 .
The prevalence of IBS 10 years after the outbreak was 43% (248 of 576) in the exposed group and 14% (94 of 685) in the control group, giving an aOR for IBS among the Giardia exposed of 4.74 (95% CI, 3.61-6.23). The AFE for IBS was among Giardia exposed was 68% (95% CI, 61%-74%).
The prevalence of CF was 26% (153 of 587) among exposed and 11% (73 of 692) among controls, with an aOR of 3.01 (95% CI, 2.22-4.08). The AFE for CF was 60% (95% CI, 48%-69%). Corresponding figures for the subgroup outcomes are presented in Table 3 .
The prevalence of IBS was 44% (169 of 388) among women in the exposed group and 42% (79 of 188) among men (P ¼ .79). The prevalence of IBS among women in the control group was 16% (71 of 446) and among men it was 10% (23 of 239, P ¼ .03). The Breslow-Day test for interaction between exposure and sex was negative (P ¼ .10). Sex was not a risk factor for CF in any of the groups. Age was not a risk factor for any of the conditions in either of the groups.
The decrease in prevalence of IBS in the exposed cohort from 3 (47%) to 6 (40%) years (as previously reported 8 ) had an aOR for the change of 0.73 (95% CI, 0.62-0.86). The decrease in prevalence of IBS from 3 (47%) to 10 (43%) years in this cohort had an aOR for the change of 0.75 (95% CI, 0.63-0.90). No change was found from 6 to 10 years. In the control group, there were no changes in prevalence of IBS for any time period (Table 4) .
The prevalence of CF in the exposed cohort decreased from 3 (47%) to 6 (31%) years 8 after exposure with an aOR for the change of 0.53 (95% CI, 0.46-0.62), from 3 to Figure 1 . The contents of Table 5 visualized as Sankey diagrams. Letters A-H in Table 5 correspond to lines A-H in the figure graphic. The thickness of the lines corresponds to the proportion of that particular group relative to the population of 399 for the exposed group and 356 for the control group.
10 years (aOR for the change 0.40; 95% CI, 0.33-0.48) and from 6 (31%) to 10 (26%) years with an aOR of 0.74 (95% CI, 0.61-0.90). In the control cohort, there were no changes in prevalence of CF for any time period (Table 4) . No interaction was found by sex or age on the time changes for either IBS or CF. The corresponding figures for the subgroup outcomes are presented in Table 4 .
The main outcomes IBS and CF were dichotomous and were measured at 3 different time points. Hence, there were 8 possible trajectories for the subgroup of respondents (n ¼ 755 for IBS, n ¼ 770 for CF) who answered at all time points and were not missing for the variables of interest (Table 5 and Figure 1 for IBS and  Supplementary Table 3 with figure for CF). Persistent IBS was more common among exposed (99 of 399, 25%) than among control subjects (6 of 356, 1.7%) with an aOR for persistent IBS among the exposed of 19.3 (95% CI, 8.3-44.7). Persistent CF was reported among 57 of 406 (14%) of the exposed and 3 of 364 (0.82%) of the control subjects with an aOR for CF among exposed of 20.5 (95% CI, 6.3-66.2). The prevalence of IBS subtypes among the 248 exposed individuals with IBS after 10 years was 11% for IBS with constipation, 44% for IBS with diarrhea, 38% for mixed subtype, and 7% for unsubtyped. Corresponding numbers for 3-and 6-year follow-ups are available as Supplementary Table 4 . IBS subtype was stable over time in 33 of 99 exposed individuals with persisting IBS (33%) whereas the rest shifted between the 4 subtypes between follow-ups (see Supplementary  Tables 5 and 6 for details).
Discussion
The main finding in this study was that the prevalence and odds ratio of both IBS and CF remained high 10 years after the acute giardiasis. The prevalence of IBS decreased from 3 to 6 years and 3 to 10 years after exposure, while there was no change from 6 to 10 years. The prevalence of CF fell over the 3 time points. Giardia exposure was strongly associated with persistence of IBS and CF.
Strengths and Limitations
A strength of this study was the fact that all participants in the exposed cohort had a laboratory-defined diagnosis of giardiasis during a verified outbreak, which is not always the case in studies of PI-IBS. 5 Possible coinfection with other pathogens has not systematically been ruled out in this cohort, but we consider the risk of coinfection to be low. Robertson et al 22 found clinically significant coinfection with Cryptosporidium parvum unlikely. Further, this was a well-defined outbreak where an unspecified number of the first patients from the outbreak had been investigated for bacterial gastroenteritis in accordance with the local laboratory's standard panel with a negative result. The contaminated drinking water was purified by chlorination, which is effective against bacteria, but not Giardia.
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Despite a decreased response rate after 10 years, our study cohorts still had a high number of participants (590 for exposed individuals, 696 for control subjects), which increased the power of the study. As 427 exposed and 365 control subjects answered at all follow-up times, this study represented a unique opportunity to follow the natural course of the conditions IBS and CF over Table 4 . (Table 5 with Figure 1 and Supplementary Table 3 with figure) .
The response rate in the exposed cohort declined from 65% after 3 years (9) to 50% after 10 years, and selection bias cannot be ruled out. The subgroup of exposed who answered at all time points could possibly be more selected than the exposed group as a whole. However, this group had a prevalence of IBS and CF comparable to the whole group. In a simulated scenario with maximum bias in the exposed group (Supplementary Table 2 ) we found that both IBS and CF were still associated with exposure 10 years after infection (ORs, 1.7 and 1.3, respectively). This finding strengthens the conclusions of the current study. The predominance of women in the exposed group has been explained in part by women drinking more tap water, increasing the probability of clinical infection. 15 The fact that the prevalence of IBS and CF remained largely unchanged at all time points in the control group at a level that is comparable to the Norwegian normal population 23, 24 suggests that selection bias is not a major problem in the control group.
Baseline information about respondents in this study was not available, including preoutbreak prevalence of IBS, psychological profile, and other comorbidities. Three studies from this outbreak have addressed the issue of preoutbreak abdominal symptoms, without clear evidence of an association between pre-existing abdominal complaints and postinfectious complications. 9 The control group was recruited from the same area as the outbreak, and hence we included a question to exclude control subjects who self-reported a physicianverified diagnosis of giardiasis in 2004. This reduced the probability of including control subjects with clinical giardiasis, which could have led to an underestimation of the association between Giardia exposure and the outcomes.
Interpretation
The prevalence of IBS among the exposed (43%) in our study 10 years after the acute infection is high compared with other studies on PI-IBS. One review found a range of prevalence of PI-IBS after epidemic infections between 7% and 36%, where all the studies included had a shorter follow-up time than 10 years. 5 This unexpectedly high prevalence of IBS after 10 years could be partly explained by a general increase in diagnoses of functional bowel diseases in the society as a whole due to increasing awareness of these conditions in the population. There was a time lag before the outbreak was recognized, 15 and some patients probably had giardiasis for some time before they received treatment, possibly increasing the risk for developing PI-IBS. Previous studies have concluded that chronic giardiasis or lactose-intolerance cannot explain the high prevalence of IBS in this cohort. 9, 25 Due to the heterogeneity among studies on PI-IBS, direct comparisons of the results are challenging. We found a strong association between Giardia exposure and IBS 10 years after exposure. A recently published 10-year follow-up study found a significant association between exposure to shigellosis and PI-IBS 1 and 3 years after the infection, but no significant association 5, 8, or 10 years later. 7 The Walkerton outbreak had a follow-up time of 8 years, and found that exposure to a mixture of bacterial pathogens was associated with PI-IBS 8 years after exposure, with a prevalence of PI-IBS among exposed of 15.4%. 6 Previous research has suggested that bacterial pathogens cause longer lasting symptoms of PI-IBS than viral pathogens. 10 Our findings suggest that PI-IBS after infection with the parasite Giardia may have a poorer prognosis than after both bacterial and viral infections. Other studies have found younger age and female sex to be risk factors for the development of PI-IBS following infection, 10 but we did not replicate this finding among the exposed in our study. Female sex is also known as a risk factor for IBS among sporadic cases. 26 We found that significantly more women than men had IBS in the control group, but no sex difference in the exposed group. This possible interaction of sex on exposure effect on IBS was not statistically significant when performing the Breslow-Day test.
Before the 2004 Giardia outbreak in Bergen, few studies had investigated long-term associations between gastrointestinal infection and CF. Previous studies on postinfectious fatigue are heterogeneous, and the definition of CF varies. Some studies 12 have investigated CFS, not to be confused with CF as defined in our study. With these limitations in mind, it nevertheless seems clear that postinfectious CI is a condition 8, [11] [12] [13] [14] to be considered in the clinic, and our study adds evidence to this. While the prevalence of IBS among the exposed in our cohort fell somewhat from 3 to 6 years but then seemed to plateau at a high prevalence, CF after Giardia infection seemed to have a better prognosis, as the prevalence fell also from 6 to 10 years after acute giardiasis. The difference in prognosis could partly be due to different therapeutic interventions received during follow-up, but our questionnaire did not assess this.
From Table 5 and Figure 1 it is clear that there was a considerable change to and from the criteria-based IBS diagnosis among both the exposed and the control group from time point to time point. This probably reflects some of the true incident and recovered cases of IBS over a time span, but it could also reflect the fact that although IBS is considered a chronic condition, it is also a condition that has fluctuating symptoms over time. 26 The stability of the IBS subtype among exposed with persisting IBS was also low, in line with the findings from the 8-year follow-up of the Walkerton outbreak. 6 Interestingly, there was a strong association between exposure and persistent IBS (IBS criteria met at all 3 follow-ups). This may be due to the fact that respondents in the exposed group on average probably had a closer relation in time to at least 1 possible IBS causing factor (Giardia exposure), than the control group, whose IBS causing factor(s) were unknown.
Through follow-up of a cohort of laboratory verified Giardia exposed and their controls at 3, 6, and 10 years after exposure, we now have more knowledge about the natural history of long-term complications after this infection. IBS and CF both remained associated with exposure even 10 years after the acute infection. The prevalence of CF fell through all follow-ups, whereas the IBS prevalence reached a plateau after an initial fall in prevalence. Clinicians need to consider both these conditions when a patient with a known history of gastrointestinal infection presents with unexplained symptoms even long after the acute infection is resolved.
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Methods Supplementary Text. Selection Bias Analyses
Selection bias was assessed in 2Â2 tables with stratification. Response/no response after 10 years was the outcome, and CF and IBS after 3 and 6 years, respectively, were the independent variables. The analyses were stratified according to status as exposed or controls. A scenario with maximum bias in the exposed group was simulated with the prevalence of either outcome set to be zero among nonresponders, whereas control group nonresponders were included with an assumed prevalence identical to that among control group responders. These results were not adjusted, as nonresponder responses were imputed.
Results
A higher proportion among exposed with IBS after 3 years (68%) than among exposed without IBS (60%) responded to the 10-year follow-up (OR for response after 10 years 1.4; 95% CI: 1.1 to 2.0). Among exposed with IBS after 6 years 71% responded after 10 years as compared to 64% among exposed without IBS (OR for response after 10 years 1.4; 95% CI: 1.0 to 1.9). Among controls no differences were found in response rate after 10 years dependent on IBS-status after 3 or 6 years. There were no changes in response rates at 10 years among exposed after 3 or 6 years according to CFstatus. Controls with CF after 3 years were less likely to respond after 10 years than controls without CF (46% vs. 58%, OR for response after 10 years 0.61 CI: 0.40 to 0.95), but there was no change in response rates according to CF-status after 6 years (Supplementary Table 1 ). A scenario with maximum bias in the exposed group resulted in an OR for IBS of 1.7 (95% CI 1.4 to 2.1) and for CF of 1.3 (95% CI 1.0 to 1.6) (Supplementary Table 2 ). A scenario with maximum bias in the exposed group was simulated with the prevalence of either outcome set to be zero among nonresponders, whereas control group nonresponders were included with an assumed prevalence identical to that among control group responders.
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